Insider Trading History of Sobecki Christopher J

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Sobecki Christopher J since 2019. This trader's CIK number is 1053892. At the time of last reporting, Sobecki Christopher J was the Director of Lexicon Pharmaceuticals, Inc.. (stock ticker symbol LXRX). Also see all insider trading activities at Lexicon Pharmaceuticals, Inc..

Note that in the past SOBECKI CHRISTOPHER J also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Lexicon Pharmaceuticals, Inc. (LXRX) by Sobecki Christopher J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 LXRX 0 $0 0 $0 36,810 $0
2024 LXRX 0 $0 0 $0 8,032 $0
2023 LXRX 0 $0 0 $0 9,302 $0
2022 LXRX 0 $0 0 $0 4,024 $0
2021 LXRX 0 $0 0 $0 10,638 $0
2020 LXRX 0 $0 0 $0 3,466 $0
2019 LXRX 124,249 $299,757 0 $0 0 $0

Yearly summary of insider trading at Ww International, Inc. (WW) by Sobecki Christopher J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 WW 0 $0 0 $0 2,053 $0
2022 WW 30,000 $125,130 0 $0 0 $0


Insider trading activities at 2 companies by Sobecki Christopher J:

1. Lexicon Pharmaceuticals, Inc. (LXRX)

2. Ww International, Inc. (WW)

Table 1. Insider trading of Lexicon Pharmaceuticals, Inc. (LXRX) by Sobecki Christopher J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-05-13 LXRX Option Ex 36,810 .00 0
2024-04-28 LXRX Option Ex 8,032 .00 0
2023-05-21 LXRX Option Ex 9,302 .00 0
2022-04-30 LXRX Option Ex 4,024 .00 0
2021-04-24 LXRX Option Ex 10,638 .00 0
2020-04-26 LXRX Option Ex 3,466 .00 0
2019-09-13 LXRX Buy 99,249 2.38 236,708
2019-09-16 LXRX Buy 25,000 2.52 63,049

Table 2. Insider trading of Ww International, Inc. (WW) by Sobecki Christopher J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-05-31 WW Option Ex 2,053 .00 0
2022-11-17 WW Buy 30,000 4.17 125,130

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sobecki Christopher J (Director of Lexicon Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.